Skip to main content
SpringerLink
Log in

Nephrology in Australia

  • Chapter
  • First Online:
Book cover Nephrology Worldwide

  • 769 Accesses

Abstract

In Australia, hospitalisations attributed to acute kidney injury are increasing at an average 6% per annum, and the vast majority of these cases are managed by critical care physicians instead of nephrologists. Prevalence of chronic kidney disease varies from 4.5% to 43.3% according to age and gender. As in other countries, most are unaware of their kidney disease. The number of people receiving maintenance dialysis has steadily increased in the last two decades with over 13,000 people on dialysis in 2017. The incidence of haemodialysis is approximately fivefold higher for Indigenous Australians compared to non-Indigenous Australians, and the magnitude of this difference has not changed in the last decade. Australia has the second highest prevalence of home haemodialysis and the fifth highest utilisation of peritoneal dialysis in the world. In recent years, average waiting time for a kidney transplant has shortened to 2.4 years for the most common blood group. Emerging paradigms in Australian nephrology include “green nephrology” and exploring different approaches to the burden of chronic kidney disease. Australia has a vibrant kidney research community, and the immediate future promises to be an incubator for nephrology clinicians who have ideas to test in our clinical spaces.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Australia|history, cities, capital, map, & facts|Britannica. https://www.britannica.com/place/Australia. Accessed 2 Dec 2019.

  2. Population clock. https://www.abs.gov.au/AUSSTATS/abs@.nsf/Web+Pages/Population+Clock?opendocument&ref=HPKI. Accessed 2 Dec 2019.

  3. 1301.0 – year book Australia, 2004. https://www.abs.gov.au/Ausstats/abs@.nsf/Previousproducts/1301.0Feature. Article 32004. Accessed 2 Dec 2019.

  4. Interesting facts about Australia’s population. https://www.abs.gov.au/websitedbs/D3310114.nsf/home/Interesting+Facts+about+Australia’s+population. Accessed 2 Dec 2019.

  5. Remote offshore territories|geoscience Australia. https://www.ga.gov.au/scientific-topics/national-location-information/dimensions/remote-offshore-territories. Accessed 2 Dec 2019.

  6. Australia is a top 20 country – Department of Foreign Affairs and Trade. https://dfat.gov.au/trade/resources/publications/Pages/australia-is-a-top-20-country.aspx. Accessed 2 Dec 2019.

  7. Dique JC. The artificial kidney in the treatment of severe puerperal infection due to Clostridium welchii, with report of a case. Med J Aust. 1955;42:781–9.

    CAS  PubMed  Google Scholar 

  8. Acute kidney injury in Australia: a first national snapshot – Australian Institute of Health and Welfare. https://www.aihw.gov.au/reports/chronic-kidney-disease/acute-kidney-injury-in-australia/contents/table-of-contents. Accessed 7 Aug 2019.

  9. Teo S, Kotwal S, Campbell C, Liu Z, Herath S, Horvath AEZ. Outcome and management of acute kidney injury (AKI) detected using electronic alerts – a prospective study from an Australian Tertiary Care Centre. Nephrology (Carlton). 2018;23:71.

    Google Scholar 

  10. Wilson GJ, Mallett A, Kark A, Tan AK, Cameron A, Wang Z, Healy HG, Hoy W. Rates and characteristics of acute kidney injury (Aki) in the chronic kidney disease in Queensland (Ckd.Qld) registry. Nephrology. 2017;22:53.

    Google Scholar 

  11. Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med. 2001;29:1910–5.

    CAS  PubMed  Google Scholar 

  12. The RENAL Study Investigators. Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey. Crit Care Resusc. 2008;10:225–30.

    Google Scholar 

  13. Levin A, Lamb EJ, White CT, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, Griffith KE, Hemmelgarn BR, Iseki K, Levey AS, Riella MC, Shlipak MG, Wang H, Winearls CG. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.

    Google Scholar 

  14. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266.

    Google Scholar 

  15. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol. 2003;14:S131–8.

    PubMed  Google Scholar 

  16. White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. Am J Kidney Dis. 2010;55:660–70.

    PubMed  Google Scholar 

  17. Australian Institute of Health and Welfare. Chronic kidney disease. Cat. no. CDK 16. Canberra: AIHW; 2019. https://www.aihw.gov.au/reports/chronic-kidney-disease/chronic-kidney-disease. Accessed 23 Sep 2019.

    Google Scholar 

  18. National health survey: first results, 2017-18. https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/bySubject/4364.0.55.001~2017-18~MainFeatures~Kidneydisease~65. Accessed 23 Sep 2019.

  19. Australia Bureau of Statistics. Australian health survey: biomedical results for chronic diseases, 2011-12. Canberra: ABS; 2013. https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4364.0.55.0052011-12. Accessed 23 Sep 2019.

    Google Scholar 

  20. AIHW. National mortality database. https://meteor.aihw.gov.au/content/index.phtml/itemId/395084. Accessed 23 Sep 2019.

  21. Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG. CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia. BMC Nephrol. 2017;18:189.

    PubMed  PubMed Central  Google Scholar 

  22. Zhang J, Healy HG, Venuthurupalli SK, Tan K-S, Wang Z, Cameron A, Hoy WE. Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia. BMC Nephrol. 2019;20:348.

    PubMed  PubMed Central  Google Scholar 

  23. Zhang J, Healy HG, Baboolal K, et al. Frequency and consequences of acute kidney injury in patients with CKD: a registry study in Queensland Australia. Kidney Med. 2019;1:180–90.

    PubMed  PubMed Central  Google Scholar 

  24. Venuthurupalli SK, Healy H, Fassett R, Cameron A, Wang Z, Hoy WE. Chronic kidney disease, Queensland: profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report. Nephrology. 2019;24:1257.

    PubMed  Google Scholar 

  25. Mallett A, Patel C, Salisbury A, Wang Z, Healy H, Hoy W. The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia. Orphanet J Rare Dis. 2014;9:98.

    PubMed  PubMed Central  Google Scholar 

  26. ANZDATA 40th annual report 2017 – ANZDATA. https://www.anzdata.org.au/report/anzdata-40th-annual-report-2017/. Accessed 7 Aug 2019.

  27. Fletcher J, McDonald S, Alexander SI. Prevalence of genetic renal disease in children. Pediatr Nephrol. 2013;28:251–6.

    PubMed  Google Scholar 

  28. Savige JA. The gene corresponding to the putative Goodpasture antigen is present in Alport’s syndrome. Clin Exp Immunol. 1991;85:236–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Savige JA, Mavrova L, Kincaid-Smith P. Inhibitable anti-GBM antibody activity after renal transplantation in Alport’s syndrome. Transplantation. 1989;48:704–5.

    CAS  PubMed  Google Scholar 

  30. Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F. Expert guidelines for the management of alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013;24:364–75.

    CAS  PubMed  Google Scholar 

  31. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY. Thin basement membrane nephropathy. Kidney Int. 2003;64:1169–78.

    PubMed  Google Scholar 

  32. Rangan GK, Savige J. Introduction to the KHA-CARI guidelines on ADPKD. Semin Nephrol. 2015;35:521–3.

    PubMed  Google Scholar 

  33. Rangan GK, Alexander SI, Campbell KL, et al. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease. Nephrology. 2016;21:705–16.

    PubMed  Google Scholar 

  34. Tong A, Tunnicliffe DJ, Lopez-Vargas P, et al. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease. Nephrology. 2016;21:122–32.

    PubMed  Google Scholar 

  35. Wong ATY, Mannix C, Grantham JJ, et al. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD). BMJ Open. 2018;8:1–13.

    Google Scholar 

  36. Takasato M, Er PX, Chiu HS, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2015;526:564–8.

    CAS  PubMed  Google Scholar 

  37. Howden SE, Thomson JA, Little MH. Simultaneous reprogramming and gene editing of human fibroblasts. Nat Protoc. 2018;13:875–98.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Haynes JM, Selby JN, Vandekolk TH, et al. Induced pluripotent stem cell–derived podocyte-like cells as models for assessing mechanisms underlying heritable disease phenotype: initial studies using two Alport syndrome patient lines indicate impaired potassium channel activity. J Pharmacol Exp Ther. 2018;367:335–47.

    CAS  PubMed  Google Scholar 

  39. Forbes TA, Howden SE, Lawlor K, et al. Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype and reveal underlying pathogenetic mechanisms. Am J Hum Genet. 2018;102:816–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Jayasinghe K, Quinlan C, Stark Z, Patel C, Mallawaarachchi A, Wardrop L, Kerr PG, Trnka P, Mallett AJ. Renal genetics in Australia: kidney medicine in the genomic age. Nephrology. 2019;24:279–86.

    PubMed  Google Scholar 

  41. Mallett AJ, McCarthy HJ, Ho G, et al. Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders. Kidney Int. 2017;92:1493–506.

    CAS  PubMed  Google Scholar 

  42. Mallett A, Fowles LF, McGaughran J, Healy H, Patel C. A multidisciplinary renal genetics clinic improves patient diagnosis. Med J Aust. 2016;204:58–9.

    PubMed  Google Scholar 

  43. Jayasinghe K, Quinlan C, Stark Z, Patel C, Sampson MG, Saleem M, Mallett AJ. Meeting report of the 2017 KidGen Renal Genetics Symposium. Hum Genomics. 2018;12:5.

    PubMed  PubMed Central  Google Scholar 

  44. Rasmussen M, Guo X, Wang Y, et al. An aboriginal Australian genome reveals separate human dispersals into Asia. Science. 2011;334:94–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Australian Bureau of Statistics Census of Population and Housing: Australia revealed, 2016. https://www.abs.gov.au/ausstats/abs@.nsf/0/63230DE0557F3B83CA2581470023C559?Opendocument. Accessed 26 Sep 2019.

  46. Broome R. Aboriginal Australians: a history since 1788. Auckland: Allen & Unwin; 2010.

    Google Scholar 

  47. ANZDATA Registry. 41st report, chapter 10: end stage kidney disease in Indigenous peoples of Australia and Aotearoa/New Zealand. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2018. http://www.anzdata.org.au. Accessed 28 Sep 2019.

    Google Scholar 

  48. Hoy WE, Hughson MD, Bertram JF, Douglas-Denton R, Amann K. Nephron number, hypertension, renal disease, and renal failure. J Am Soc Nephrol. 2005;16:2557–64.

    PubMed  Google Scholar 

  49. Lawton PD, McDonald SP, Snelling PL, Hughes J, Cass A. Organ transplantation in Australia: inequities in access and outcome for Indigenous Australians. Transplantation. 2017;101:e345–6.

    PubMed  Google Scholar 

  50. Rogers NM, Lawton PD, Jose MD. Kidney transplant outcomes in the Indigenous population in the Northern Territory of Australia. Transplantation. 2006;82:882–6.

    PubMed  Google Scholar 

  51. George CR. History of home haemodialysis in Australia. Nephrology. 2005;10:215–21.

    PubMed  Google Scholar 

  52. ANZDATA 42nd annual report 2019 – ANZDATA. https://www.anzdata.org.au. Accessed 28 Sep 2019.

  53. ANZDATA Registry. 41st report, chapter 4: haemodialysis. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2018. http://www.anzdata.org.au. Accessed 22 Aug 2019.

    Google Scholar 

  54. Mac K, Hedley J, Kelly PJ, et al. Effect of centre- and patient-related factors on uptake of haemodiafiltration in Australia and New Zealand: a cohort study using ANZDATA. Nephrology. 2019;25:63.

    PubMed  Google Scholar 

  55. Kerr PG, Toussaint ND, Kidney Health Australia, Caring for Australasians with Renal Impairment. KHA-CARI guideline: dialysis adequacy (haemodialysis): dialysis membranes. Nephrology. 2013;18:485–8.

    PubMed  Google Scholar 

  56. ANZDATA Registry. 41st report, chapter 1: incidence of end stage kidney disease. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2018. http://www.anzdata.org.au. Accessed 28 Sep 2019.

    Google Scholar 

  57. Wolley MJ, Hawley CM, Johnson DW, Marshall MR, Roberts MA. Incremental and twice weekly haemodialysis in Australia and New Zealand. Nephrology (Carlton). 2019;24:1172.

    Google Scholar 

  58. Australian regulatory guidelines for medical devices (ARGMD), V1.1|Therapeutic Goods Administration (TGA). https://www.tga.gov.au/publication/australian-regulatory-guidelines-medical-devices-argmd-v11. Accessed 2 Dec 2019.

  59. See EJ, Hedley J, Agar JWM, et al. Patient survival on haemodiafiltration and haemodialysis: a cohort study using the Australia and New Zealand Dialysis and Transplant Registry. Nephrol Dial Transplant. 2019;34:326–38.

    CAS  PubMed  Google Scholar 

  60. Curtis FK, Cole JJ, Fellows BJ, Tyler LLSB. Hemodialysis in the home. Am Soc Artif Intern Organs. 1965;11:7–10.

    CAS  Google Scholar 

  61. Merrill JP, Schupak E, Cameron E, Hampers CL. Hemodialysis in the home. JAMA. 1964;190:468–70.

    CAS  PubMed  Google Scholar 

  62. Baillod RA, Comty C, Ilahi M, Konotey-Ahulu FID, Sevitt LSS. Overnight haemodialysis in the home. Proc Eur Dial Transpl Assoc. 1965;2:99–103.

    Google Scholar 

  63. Dawborn JK, Marshall VC. Home dialysis: a case report. Med J Aust. 1968;2:837–40.

    CAS  PubMed  Google Scholar 

  64. Nosé Y. Home hemodialysis: a crazy idea in 1963: a memoir. ASAIO J. 2000;46:13–7.

    PubMed  Google Scholar 

  65. Report of the ad-hoc committee on rationalisation of facilities for organ transplantation and renal dialysis. Med J Aust. 1968;2:1200–8.

    Google Scholar 

  66. Agar JWM, Somerville CA, Dwyer KM, Simmonds RE, Boddington JM, Waldron CM. Nocturnal hemodialysis in Australia. Hemodial Int. 2003;7:278–89.

    PubMed  Google Scholar 

  67. United States renal data system. https://www.usrds.org/2018/view/v2_11.aspx. Accessed 19 Aug 2019.

  68. Chow J. A pre-training assessment tool for home dialysis (JPAT). EDTNA ERCA J. 2005;31:19–23.

    CAS  PubMed  Google Scholar 

  69. Home Dialysis Central|MATCH-D. https://homedialysis.org/match-d. Accessed 19 Aug 2019.

  70. Muir CA, Kotwal SS, Hawley CM, Polkinghorne K, Gallagher MP, Snelling P, Jardine MJ. Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review. Clin J Am Soc Nephrol. 2014;9:110–9.

    PubMed  Google Scholar 

  71. Walker RC, Hanson CS, Palmer SC, Howard K, Morton RL, Marshall MR, Tong A. Patient and caregiver perspectives on home hemodialysis: a systematic review. Am J Kidney Dis. 2015;65:451. https://doi.org/10.1053/j.ajkd.2014.10.020.

    Article  PubMed  Google Scholar 

  72. Walker R, Howard K, Morton R. Home hemodialysis: a comprehensive review of patient-centered and economic considerations. Clin Outcomes Res. 2017;9:149–61.

    Google Scholar 

  73. Kidney Health Australia. Financial support for home dialysis patients in Australia 2. https://kidney.org.au/cms_uploads/docs/home-dialysis-financial-assistance-electricity-water-and-subsidies.pdf. Accessed 19 Aug 2019.

  74. Independent Hospital Pricing Authority Home delivered dialysis costing study to inform the National Efficient Price 2015. 2014. Final Report.

    Google Scholar 

  75. Gurr F. Peritoneal dialysis. Med J Aust. 1954;2:653–5.

    Google Scholar 

  76. Wood T. Experiences with peritoneal dialysis. Med J Aust. 1965;2:150–3.

    CAS  PubMed  Google Scholar 

  77. George CRP. Caring for kidneys in the antipodes: how Australia and New Zealand have addressed the challenge of end-stage renal failure. Am J Kidney Dis. 2009;53:536–45.

    PubMed  Google Scholar 

  78. ANZDATA Registry. 33rd report, chapter 6: peritoneal dialysis. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2010.

    Google Scholar 

  79. Li PKT, Chow KM, Van De Luijtgaarden MWM, Johnson DW, Jager KJ, Mehrotra R, Naicker S, Pecoits-Filho R, Yu XQ, Lameire N. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13:90–103.

    CAS  PubMed  Google Scholar 

  80. Bello AK, Levin A, Lunney M, et al. (2019). Global Kidney Health Atlas: A report by the International Society of Nephrology on the Global Burden of End-stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across World Countries and Regions. International Society of Nephrology, Brussels, Belgium.

    Google Scholar 

  81. Liu FX, Gao X, Inglese G, Chuengsaman P, Pecoits-Filho R, Yu A. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Perit Dial Int. 2015;35:406–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Jain AK, Blake P, Cordy P, Garg AX. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol. 2012;23:533–44.

    PubMed  PubMed Central  Google Scholar 

  83. Johnson DW, Brown FG, Clarke M, et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol. 2012;23:1097–107.

    PubMed  PubMed Central  Google Scholar 

  84. Cho Y, Boudville N, Palmer SC, et al. Practice of peritoneal dialysis catheter flushing in Australia and New Zealand: multi-center cross-sectional survey. Perit Dial Int. 2018;38:98–103.

    CAS  PubMed  Google Scholar 

  85. Boudville N, Johnson DW, Zhao J, et al. Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the peritoneal dialysis outcomes and practice patterns study. Nephrol Dial Transpl. 2018;34:2118.

    Google Scholar 

  86. Boudville N, Cho Y, Equinox KL, et al. Teaching peritoneal dialysis in Australia: an opportunity for improvement. Nephrology. 2018;23:259–63.

    PubMed  Google Scholar 

  87. Lan PG, Clayton PA, Johnson DW, McDonald SP, Borlace M, Badve SV, Sud K, Boudville N. Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: proposal for a standardized definition of technique failure. Perit Dial Int. 2016;36:623–30.

    PubMed  PubMed Central  Google Scholar 

  88. Htay H, Cho Y, Pascoe EM, et al. Center effects and peritoneal dialysis peritonitis outcomes: analysis of a National Registry. Am J Kidney Dis. 2018;71:814–21.

    PubMed  Google Scholar 

  89. Nadeau-Fredette AC, Johnson DW, Hawley CM, et al. Center-specific factors associated with peritonitis risk—a multi-center registry analysis. Perit Dial Int. 2016;36:509–18.

    PubMed  PubMed Central  Google Scholar 

  90. Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, McDonald SP. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int. 2011;31:651–62.

    PubMed  Google Scholar 

  91. Nataatmadja M, Cho Y, Johnson DW. Continuous quality improvement initiatives to sustainably reduce peritoneal dialysis-related infections in Australia and New Zealand. Perit Dial Int. 2016;36:472–7.

    PubMed  PubMed Central  Google Scholar 

  92. Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014;64:278–89.

    PubMed  Google Scholar 

  93. Jose MD, Johnson DW, Mudge DW, Tranaeus A, Voss D, Walker R, Bannister KM. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology. 2011;16:19–29.

    PubMed  Google Scholar 

  94. Mudge DW, Boudville N, Brown F, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to sustain the action. Nephrology. 2016;21:535–46.

    PubMed  Google Scholar 

  95. Johnson DW, Badve SV, Pascoe EM, et al. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. Lancet Infect Dis. 2014;14:23–30.

    PubMed  Google Scholar 

  96. Campbell DJ, Brown F, Craig J, Gallagher M, Johnson DW, Kirkland G, Kumar SK, Lim WH, Ranganathan D, Saweirs W, Sud K, Toussaint ND, Walker RG, Yehia MMD. Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients. Nephrology. 2014;19:42.

    Google Scholar 

  97. Chow JSF, Cho Y, Equinox K-L, et al. An intervention design: supporting skills development for peritoneal dialysis trainers. Perit Dial Int. 2019;39:134–41.

    PubMed  Google Scholar 

  98. Medicare benefits schedule book. http://www.health.gov.au/mbsonline. Accessed 2 Dec 2019.

  99. Gorham G, Howard K, Zhao Y, et al. Cost of dialysis therapies in rural and remote Australia – a micro-costing analysis. BMC Nephrol. 2019;20:231.

    CAS  PubMed  PubMed Central  Google Scholar 

  100. State of Queensland (Queensland Health). Health funding principles and guidelines 2017–18 financial year. https://www.health.qld.gov.au/__data/assets/pdf_file/0021/707133/funding_guidelines.pdf. Accessed 2 Dec 2019.

  101. Zhao Y, Poppe S, Lawton P, Hutchings J, You JQ, Annesley K, Cameron N, Guthridge S. Satellite dialysis costs in the top end, 2011-2013. In: Dep. Heal. Darwin, 2014. https://digitallibrary.health.nt.gov.au/prodjspui/bitstream/10137/1316/1/Satellite%20Dialysis%20Costs_Renal%20costing%20report.pdf. Accessed 2 Dec 2019.

  102. Funding for renal services in Victoria – health.vic. https://www2.health.vic.gov.au/hospitals-and-health-services/patient-care/rehabilitation-complex-care/renal-health/funding-for-renal-services. Accessed 2 Dec 2019.

  103. Cass A, Chadban S, Gallagher M, Howard K, Jones A, Mcdonald S, Snelling P, White S. The economic impact of end-stage kidney disease in Australia. Projections to 2020. Melbourne: Kidney Health Australia; 2010.

    Google Scholar 

  104. Chapman JR. Transplantation in Australia – 50 years of progress. Med J Aust. 1992;157:46–50.

    CAS  PubMed  Google Scholar 

  105. Australian and New Zealand Paired Kidney Exchange (ANZKX) Program|DonateLife. https://donatelife.gov.au/about-donation/living-donation/australian-and-new-zealand-paired-kidney-exchange-anzkx-program. Accessed 7 Aug 2019.

  106. Australian Donation and Transplantation Activity Report. 2018. www.donatelife.gov.au. Accessed 1 Dec 2019.

  107. ANZOD Registry. 2018 annual report, section 4: deceased organ donor profile. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2018. www.anzdata.org.au. Accessed 8 Jul 2019.

    Google Scholar 

  108. Transplantation Society of Australia and New Zealand. TSANZ clinical guidelines version 1.3 May 2019. www.tsanz.com.au/organallocationguidelines/index.asp. Accessed 8 Jul 2019.

  109. National Health and Medical Research Council. Ethical guidelines for organ transportation from deceased donors. Canberra: National Health and Medical Research Council; 2016. www.nhmrc.gov.au/guidelines/publications/E76. Accessed 8 Jul 2019.

    Google Scholar 

  110. ANZDATA Registry. 41st report, chapter 6: Australian transplant waiting list. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2019. www.anzdata.org.au. Accessed 8 Jul 2019.

    Google Scholar 

  111. McDonald SP. Australia and New Zealand dialysis and transplant registry. Kidney Int Suppl. 2015;5:39–44.

    Google Scholar 

  112. McDonald SP. Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. Nephrol Dial Transplant. 2002;17:2212–9.

    PubMed  Google Scholar 

  113. Clayton PA, McDonald SP, Snyder JJ, Salkowski N, Chadban SJ. External validation of the estimated posttransplant survival score for allocation of deceased donor kidneys in the United States. Am J Transplant. 2014;14:1922–6.

    CAS  PubMed  Google Scholar 

  114. Hall J. Australian Health Care — the challenge of reform in a fragmented system. N Engl J Med. 2015;373:493–7.

    CAS  PubMed  Google Scholar 

  115. Peabody JW, Bickel SR, Lawson JS. The Australian health care system. Are the incentives down under right side up? JAMA. 1996;276:1944–50.

    CAS  PubMed  Google Scholar 

  116. Fullman N, Yearwood J, Abay SM, et al. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018;391:2236–71.

    Google Scholar 

  117. Australian Institute of Health and Welfare. End-stage kidney disease in Australia: total incidence, 2003–2007. Cat. no. PHE 143. Canberra: AIHW; 2011. www.aihw.gov.au. Accessed 7 Aug 2019.

    Google Scholar 

  118. Australian Institute of Health and Welfare. Chronic kidney disease: regional variation in Australia. Cat. no. PHE 172. Canberra: AIHW; 2013. www.aihw.gov.au. Accessed 7 Aug 2019.

    Google Scholar 

  119. Osman MA, Alrukhaimi M, Ashuntantang GE, et al. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney Int Suppl. 2018;8:52–63.

    Google Scholar 

  120. Glenn D, Ocegueda S, Nazareth M, Zhong Y, Weinstein A, Primack W, Cochat P, Ferris M. The global pediatric nephrology workforce: a survey of the International Pediatric Nephrology Association. BMC Nephrol. 2016;17:83.

    PubMed  PubMed Central  Google Scholar 

  121. Costello A, Abbas M, Allen A, et al. Managing the health effects of climate change. Lancet. 2009;373:1693–733.

    PubMed  Google Scholar 

  122. Watts N, Adger WN, Agnolucci P, et al. Health and climate change: policy responses to protect public health. Lancet. 2015;386:1861–914.

    PubMed  Google Scholar 

  123. Foley JA, Monfreda C, Ramankutty N, Zaks D. Our share of the planetary pie. Proc Natl Acad Sci. 2007;104:12585–6.

    CAS  PubMed  Google Scholar 

  124. Eckelman MJ, Sherman J. Environmental impacts of the U.S. health care system and effects on public health. PLoS One. 2016;11:e0157014.

    PubMed  PubMed Central  Google Scholar 

  125. Malik A, Lenzen M, McAlister S, McGain F. The carbon footprint of Australian health care. Lancet Planet Heal. 2018;2:e27–35.

    Google Scholar 

  126. Agar JWM. Green dialysis: the environmental challenges ahead. Semin Dial. 2015;28:186–92.

    PubMed  Google Scholar 

  127. Agar JWM. Reusing and recycling dialysis reverse osmosis system reject water. Kidney Int. 2015;88:653–7.

    CAS  PubMed  Google Scholar 

  128. Lim AEK, Perkins A, Agar JWM. The carbon footprint of an Australian satellite haemodialysis unit. Aust Health Rev. 2013;37:369–74.

    PubMed  Google Scholar 

  129. Agar JW. Conserving water in and applying solar power to haemodialysis: “green dialysis” through wiser resource utilization: original article. Nephrology. 2010;15:448–53.

    PubMed  Google Scholar 

  130. Agar JWM, Perkins A, Tjipto A. Solar-assisted hemodialysis. Clin J Am Soc Nephrol. 2012;7:310–4.

    PubMed  PubMed Central  Google Scholar 

  131. Win-win as dialysis waste reinforces concrete|Engineers Australia. https://www.engineersaustralia.org.au/News/win-win-dialysis-waste-reinforces-concrete. Accessed 7 Aug 2019.

  132. This innovative concrete recipe doubles as a way to recycle medical waste – Create digital magazine. https://www.createdigitalmagazine.org.au/concrete-doubles-recycle-medical-waste/. Accessed 7 Aug 2019.

  133. Blankestijn PJ, Arici M, Bruchfeld A, et al. ERA-EDTA invests in transformation to greener health care. Nephrol Dial Transplant. 2018;33:901–3.

    PubMed  Google Scholar 

  134. Moura-Neto JA, Barraclough K, Agar JWM. A call-to-action for sustainability in dialysis in Brazil. J Bras Nefrol. 2019;41:560.

    PubMed  PubMed Central  Google Scholar 

  135. Barraclough KA, Holt SG, Agar JWM. Climate change and us: what nephrologists should know. Nephrology. 2015;20:760–4.

    PubMed  Google Scholar 

  136. Barraclough KA, Blashki GA, Holt SG, Agar JWM. Climate change and kidney disease—threats and opportunities. Kidney Int. 2017;92:526–30.

    PubMed  Google Scholar 

  137. Blankestijn PJ, Bruchfeld A, Capasso G, et al. Lancet countdown paper: what does it mean for nephrology? Nephrol Dial Transplant. 2019;34:4–6.

    PubMed  Google Scholar 

  138. Wouters OJ, O’Donoghue DJ, Ritchie J, Kanavos PG, Narva AS. Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol. 2015;11:491.

    PubMed  PubMed Central  Google Scholar 

  139. Gois P, Purtell L, Bonner A, Chang GK, Lal V, Cation A, Kark AL, et al. The keeping kidneys program: baseline results form a new model of care for community kidney health. J. Am. Soc. Nephrol. Abstr. Suppl. 2019;30;1180. American Society of Nephrology Kidney Week 2019 Nov 5–10; Washington DC.

    Google Scholar 

  140. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.

    CAS  Google Scholar 

  141. Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013;3:368.

    Google Scholar 

  142. Queensland Government. Queensland statewide renal health services plan, 2008–17, part one: the way forward. Brisbane: Queensland Government; 2007.

    Google Scholar 

  143. Renal integrated care pathway guide for Victorian renal services – June 2016 – health.vic. https://www2.health.vic.gov.au/about/publications/policiesandguidelines/renal-integrated-care-pathway. Accessed 6 Sep 2019.

  144. Tasmanian Government. Tasmanian state plan for renal services 2010-2020, part one: overview and action plan. Hobart: Tasmanian Government; 2009.

    Google Scholar 

  145. Renal Network NSW. https://www.aci.health.nsw.gov.au/networks/renal. Accessed 6 Sep 2019.

  146. Statewide Renal Clinical Network. South Australian statewide renal key performance indicators statewide renal clinical network. 2014. https://www.sahealth.sa.gov.au/wps/wcm/connect/9010bd80453022288e54de005ba75f87/SA-Renal-KPI%27s-Feb-2014-final.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-9010bd80453022288e54de005ba75f87-mN5EgMd. Accessed 6 Sep 2019.

  147. Northern Territory Renal services strategy 2017 – 2022. https://digitallibrary.health.nt.gov.au/prodjspui/handle/10137/1438. Accessed 6 Sep 2019.

  148. Renal Health Network Western Australia. https://ww2.health.wa.gov.au/Articles/N_R/Renal-Health-Network. Accessed 6 Sep 2019.

Download references

Author information

Authors and Affiliations

  1. Nephrology Department, Royal Brisbane & Women’s Hospital, Brisbane, QLD, Australia

    Pedro Henrique Franca Gois, Helen G. Healy, Dwarakanathan Ranganathan & Marina Wainstein

  2. University of Queensland School of Clinical Medicine - Royal Brisbane Clinical Unit, QLD, Australia

    Pedro Henrique Franca Gois

  3. School of Medicine, Griffith University, Brisbane, QLD, Australia

    Dwarakanathan Ranganathan

  4. Department of Renal Medicine, Townsville University Hospital, Douglas, QLD, Australia

    Andrew John Mallett

  5. Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia

    Angela C. Webster

  6. Department of Nephrology, Monash Health and Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, VIC, Australia

    John Kanellis

  7. Nephrology, Royal Melbourne Hospital, Parkville, VIC, Australia

    Katherine Barraclough

  8. Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, QLD, Australia

    David W. Johnson

  9. Nephrology, Monash Health and Monash University, Clayton, VIC, Australia

    Peter G. Kerr

Authors
  1. Pedro Henrique Franca Gois
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helen G. Healy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dwarakanathan Ranganathan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrew John Mallett
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Angela C. Webster
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John Kanellis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katherine Barraclough
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marina Wainstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. David W. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Peter G. Kerr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro Henrique Franca Gois .

Editor information

Editors and Affiliations

  1. Brazilian Society of Nephrology, Salvador, Bahia, Brazil

    José A. Moura-Neto

  2. Division of Renal Medicine, CLINTEC, Karolinska Institutet, Stockholm, Stockholms Län, Sweden

    José Carolino Divino-Filho

  3. DIMED - University of Padova, Department Nephrology Dialysis & Transplantation, International Renal Research Institute (IRRIV), San Bortolo Hospital, Vicenza, Italy

    Claudio Ronco

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gois, P.H.F. et al. (2021). Nephrology in Australia. In: Moura-Neto, J.A., Divino-Filho, J.C., Ronco, C. (eds) Nephrology Worldwide. Springer, Cham. https://doi.org/10.1007/978-3-030-56890-0_52

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-56890-0_52

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-56889-4

  • Online ISBN: 978-3-030-56890-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation